Results, reports and presentations
00. Letter to Shareholders – Notice of Availability
15(a)(i) Director Irrevocable Undertaking – Kirsten Lund [Redacted]
15(a)(iii) Shareholder Irrevocable – Richard Griffiths [Redacted].pdf
15(a)(iv) Shareholder Irrevocable – Lombard Odier [Redacted]
15(b) Current Memorandum and Articles of Association
15(c) New Articles of Association
15(e) Cavendish Consent Letter [Redacted]
15(g) Advance Loan [Redacted]
15(h)(i) Secured Convertible Loan Note [Redacted]
15(h)(ii) Business Loan Agreement [Redacted]
4 December 2025 Convertible Loan Note Circular
Annual Report and Financials for year ended 31 December 2024
Interim Results Presentation 2024 – 10 September 2024
Interim Results 2024 – 10 September 2024
Final results presentation for the year ended 31 December 2023 – 17 April 2024
Annual Report and Financials for year ended 31 December 2023 – 19 March 2024
Tissue Regenix new Articles of Association
Annual Report and Financials for year ended 31 December 2022
RNS
AIM - Cancellation - Tissue Regenix Group Plc 2026-01-07 07:00:00View Article
Secondary Trading Following Cancellation 2026-01-07 07:00:00 Description: Miscellaneous
View Article Result of General Meeting and Cancellation 2025-12-22 16:08:00 Description: Result of Meeting
View Article FTSE Russell - Tissue Regenix Group 2025-12-17 18:00:00View Article
Update re. proposed cancellation of shares 2025-12-08 07:00:00 Description: Miscellaneous
View Article Proposed £17.5m CLN raise, cancellation of Trading 2025-12-04 14:40:00 Description: Further
View Article Further re. financial update and funding plans 2025-12-01 07:00:00 Description: Further
View Article Financial update and funding plans 2025-11-07 07:00:00 Description: Strategy/Company/Operations Update
View Article Statement re. Suspension 2025-10-22 15:29:00 Description: Statement re. Suspension
View Article AIM - Suspension - Tissue Regenix Group PLC 2025-10-22 14:02:00View Article
CFO joins Board 2025-10-17 07:00:00 Description: Directorate change
View Article Update re. FY24 & H125 restatement & Board Changes 2025-10-16 07:00:00 Description: Strategy/Company/Operations Update
View Article Holding(s) in Company 2025-10-09 07:00:00 Description: Holding(s) in Company
View Article Holding(s) in Company 2025-10-06 15:29:00 Description: Holding(s) in Company
View Article Holding(s) in Company 2025-10-03 15:01:00 Description: Holding(s) in Company
View Article Holding(s) in Company 2025-10-02 16:43:00 Description: Holding(s) in Company
View Article Holding(s) in Company 2025-10-01 17:35:00 Description: Holding(s) in Company
View Article Half-year Report 2025-09-30 07:00:00 Description: Half-year Report
View Article Notice of Results 2025-09-17 07:00:00 Description: Notice of Results
View Article Half-Year Trading Update and Notice of Results 2025-09-08 07:01:00 Description: Trading Statement
View Article Board Changes 2025-09-08 07:00:00 Description: Directorate change
View Article Directorate Change 2025-08-01 07:00:00 Description: Directorate change
View Article Result of AGM 2025-07-23 13:52:00 Description: Result of AGM
View Article Grant of share options 2025-07-04 07:00:00 Description: Director/PDMR Shareholding
View Article Posting of Annual Report & Notice of AGM 2025-06-27 07:00:00 Description: Notice of AGM
View Article Final results for the year ended 31 December 2024 2025-06-25 07:00:00 Description: Final Results
View Article CE & UKCA certification for OrthoPure® XT 2025-06-09 07:00:00 Description: Miscellaneous
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI)- Tissue Regenix Group Plc 2025-04-24 09:38:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-04-15 09:23:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-04-10 09:09:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-04-09 10:45:00 Description: Form 8.5 (EPT/NON-RI)
View Article Conclusion of Strategic Review & Offer Period 2025-04-08 07:00:00 Description: Strategy/Company/Operations Update
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-04-07 08:46:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-04-01 09:12:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-31 09:21:00 Description: Form 8.5 (EPT/NON-RI)
View Article European patent granted 2025-03-27 07:00:00 Description: Miscellaneous
View Article Cavendish Securities - Form 8.5- Tissue Regenix Group Plc 2025-03-25 08:58:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-21 08:36:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-20 09:19:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-19 08:55:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-18 09:29:00 Description: Form 8.5 (EPT/NON-RI)
View Article Company update 2025-03-18 07:00:00 Description: Strategy/Company/Operations Update
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-12 09:27:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-10 09:30:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-06 09:29:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-05 08:54:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-04 09:28:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-03-03 09:21:00 Description: Form 8.5 (EPT/NON-RI)
View Article Cavendish Securities - Form 8.5 (EPT/NON-RI) 2025-02-21 08:56:00 Description: Form 8.5 (EPT/NON-RI)
View Article Lombard Odier - Form 8.3 - Tissue Regenix Group PLC 2025-02-20 13:46:00 Description: Form 8.3
View Article